Az endokrin pancreas öröklodo daganatai

Translated title of the contribution: Hereditary tumours of the endocrine pancreas

P. Igaz, Iván Igaz, Károly Ráz, Z. Tulassay

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The pathogenesis, diagnosis and therapy of tumours originating from the endocrine pancreas represent one of the most exciting challenges of contemporary medicine. Some of these tumours appear as part of four hereditary syndromes (multiple endocrine neoplasia type 1 (MEN1), von Hippel-Lindau disease (VHL), neurofibromatosis type 1 and tuberous sclerosis) that are all inherited as autosomal dominant traits and result from mutations of tumour suppressor genes. Considering its clinical relevance, MEN1 appears to be the most important among these four syndromes. Tumours of the endocrine pancreas develop in 30-80% of patients carrying mutations of the MEN1 gene. Gastrinomas are the most frequent functioning tumours in MEN1 patients, followed by insulinomas, whereas other tumors e.g. glucagonoma, VIP-oma, GRF-oma and somatostatinoma occur very rarely. Tumours of the endocrine pancreas are infrequent in patients suffering from VHL, neurofibromatosis and tuberous sclerosis. In this review article, the authors present a synopsis of tumours of the endocrine pancreas related to these hereditary syndromes underlining the clinical charasteristics, diagnostical and therapeutical possibilities.

Original languageHungarian
Pages (from-to)195-200
Number of pages6
JournalOrvosi Hetilap
Volume147
Issue number5
Publication statusPublished - Feb 5 2006

Fingerprint

Islets of Langerhans
Multiple Endocrine Neoplasia Type 1
Neoplasms
von Hippel-Lindau Disease
Tuberous Sclerosis
Somatostatinoma
Glucagonoma
Gastrinoma
Insulinoma
Mutation
Neurofibromatoses
Neurofibromatosis 1
Tumor Suppressor Genes
Medicine
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az endokrin pancreas öröklodo daganatai. / Igaz, P.; Igaz, Iván; Ráz, Károly; Tulassay, Z.

In: Orvosi Hetilap, Vol. 147, No. 5, 05.02.2006, p. 195-200.

Research output: Contribution to journalArticle

Igaz, P, Igaz, I, Ráz, K & Tulassay, Z 2006, 'Az endokrin pancreas öröklodo daganatai', Orvosi Hetilap, vol. 147, no. 5, pp. 195-200.
Igaz, P. ; Igaz, Iván ; Ráz, Károly ; Tulassay, Z. / Az endokrin pancreas öröklodo daganatai. In: Orvosi Hetilap. 2006 ; Vol. 147, No. 5. pp. 195-200.
@article{bc9111a6370041c9962f9aa9e6a9df29,
title = "Az endokrin pancreas {\"o}r{\"o}klodo daganatai",
abstract = "The pathogenesis, diagnosis and therapy of tumours originating from the endocrine pancreas represent one of the most exciting challenges of contemporary medicine. Some of these tumours appear as part of four hereditary syndromes (multiple endocrine neoplasia type 1 (MEN1), von Hippel-Lindau disease (VHL), neurofibromatosis type 1 and tuberous sclerosis) that are all inherited as autosomal dominant traits and result from mutations of tumour suppressor genes. Considering its clinical relevance, MEN1 appears to be the most important among these four syndromes. Tumours of the endocrine pancreas develop in 30-80{\%} of patients carrying mutations of the MEN1 gene. Gastrinomas are the most frequent functioning tumours in MEN1 patients, followed by insulinomas, whereas other tumors e.g. glucagonoma, VIP-oma, GRF-oma and somatostatinoma occur very rarely. Tumours of the endocrine pancreas are infrequent in patients suffering from VHL, neurofibromatosis and tuberous sclerosis. In this review article, the authors present a synopsis of tumours of the endocrine pancreas related to these hereditary syndromes underlining the clinical charasteristics, diagnostical and therapeutical possibilities.",
keywords = "Endocrine pancreas, MEN1, Tumour, VHL",
author = "P. Igaz and Iv{\'a}n Igaz and K{\'a}roly R{\'a}z and Z. Tulassay",
year = "2006",
month = "2",
day = "5",
language = "Hungarian",
volume = "147",
pages = "195--200",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "5",

}

TY - JOUR

T1 - Az endokrin pancreas öröklodo daganatai

AU - Igaz, P.

AU - Igaz, Iván

AU - Ráz, Károly

AU - Tulassay, Z.

PY - 2006/2/5

Y1 - 2006/2/5

N2 - The pathogenesis, diagnosis and therapy of tumours originating from the endocrine pancreas represent one of the most exciting challenges of contemporary medicine. Some of these tumours appear as part of four hereditary syndromes (multiple endocrine neoplasia type 1 (MEN1), von Hippel-Lindau disease (VHL), neurofibromatosis type 1 and tuberous sclerosis) that are all inherited as autosomal dominant traits and result from mutations of tumour suppressor genes. Considering its clinical relevance, MEN1 appears to be the most important among these four syndromes. Tumours of the endocrine pancreas develop in 30-80% of patients carrying mutations of the MEN1 gene. Gastrinomas are the most frequent functioning tumours in MEN1 patients, followed by insulinomas, whereas other tumors e.g. glucagonoma, VIP-oma, GRF-oma and somatostatinoma occur very rarely. Tumours of the endocrine pancreas are infrequent in patients suffering from VHL, neurofibromatosis and tuberous sclerosis. In this review article, the authors present a synopsis of tumours of the endocrine pancreas related to these hereditary syndromes underlining the clinical charasteristics, diagnostical and therapeutical possibilities.

AB - The pathogenesis, diagnosis and therapy of tumours originating from the endocrine pancreas represent one of the most exciting challenges of contemporary medicine. Some of these tumours appear as part of four hereditary syndromes (multiple endocrine neoplasia type 1 (MEN1), von Hippel-Lindau disease (VHL), neurofibromatosis type 1 and tuberous sclerosis) that are all inherited as autosomal dominant traits and result from mutations of tumour suppressor genes. Considering its clinical relevance, MEN1 appears to be the most important among these four syndromes. Tumours of the endocrine pancreas develop in 30-80% of patients carrying mutations of the MEN1 gene. Gastrinomas are the most frequent functioning tumours in MEN1 patients, followed by insulinomas, whereas other tumors e.g. glucagonoma, VIP-oma, GRF-oma and somatostatinoma occur very rarely. Tumours of the endocrine pancreas are infrequent in patients suffering from VHL, neurofibromatosis and tuberous sclerosis. In this review article, the authors present a synopsis of tumours of the endocrine pancreas related to these hereditary syndromes underlining the clinical charasteristics, diagnostical and therapeutical possibilities.

KW - Endocrine pancreas

KW - MEN1

KW - Tumour

KW - VHL

UR - http://www.scopus.com/inward/record.url?scp=33645523049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645523049&partnerID=8YFLogxK

M3 - Article

C2 - 16509219

AN - SCOPUS:33645523049

VL - 147

SP - 195

EP - 200

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 5

ER -